Compare WBI & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WBI | ADMA |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2025 | 2012 |
| Metric | WBI | ADMA |
|---|---|---|
| Price | $28.13 | $9.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $36.50 | $17.00 |
| AVG Volume (30 Days) | 499.0K | ★ 2.4M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.18 | ★ 0.35 |
| Revenue | ★ $525,553,000.00 | $42,219,783.00 |
| Revenue This Year | $71.53 | $4.93 |
| Revenue Next Year | $22.28 | $17.59 |
| P/E Ratio | $158.00 | ★ $28.46 |
| Revenue Growth | ★ 66.16 | 43.85 |
| 52 Week Low | $18.64 | $7.21 |
| 52 Week High | $36.89 | $20.46 |
| Indicator | WBI | ADMA |
|---|---|---|
| Relative Strength Index (RSI) | 27.72 | 61.24 |
| Support Level | $27.14 | $9.23 |
| Resistance Level | $27.57 | $10.24 |
| Average True Range (ATR) | 1.05 | 0.39 |
| MACD | -0.30 | 0.09 |
| Stochastic Oscillator | 2.20 | 95.08 |
WaterBridge Infrastructure LLC is an integrated, pure-play water infrastructure company with operations predominantly in the Delaware Basin, the prolific oil and natural gas basin in North America. It operates in the produced water infrastructure network in the United States through which it provides water management solutions to oil and natural gas E&P companies under long-term contracts, which include gathering, transporting, recycling, and handling produced water. It also operates two energy waste management facilities for the disposal of non-hazardous waste resulting from oil and gas E&P activities, branded under Desert Environmental. The transportation, treatment, and handling of produced water are crucial to oil and natural gas production.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.